 |
|
|
| |
Analysis of Resistance to the HIV-1 Integrase Inhibitor Raltegravir: Results from BENCHMRK-1 and -2
|
| |
| |
Reported by Jules Levin
Mike Miller1, Robert Danovich1, Signe Fransen2, Soumi Gupta2, Wei Huang2, Bach-Yen Nguyen1, Neil Parkin2, Christos Petropoulos2, Hedy Teppler1, Marc Witmer1, Jing Zhao1, and Daria Hazuda1.
Merck and Co.1, West Point, PA
and Monogram Biosciences2, S. San Francisco, CA
Copyright Merck & Co. Inc, Whithouse Station, New Jersey, USA, All rights Reserved
Update on resistance
Recent insights into mechanism of action
|
| |
|
|
|
|
|
